Skip to main content

Table 3 Stepwise linear regression analysis predicting the PTSD symptom severity by FGM (dummy coded with FGM I at baseline; step 1), FGM and the number of lifetime traumatic events (step 2) and the latter variables and their interaction term

From: Psychopathological sequelae of female genital mutilation and their neuroendocrinological associations

  beta (SE) β t
Step 1 (F(2,162) = 7.3, p < .001, adjusted R2 = .07, f2 = .09)
 (Intercept) 0.83 (1.34) .09 0.42
 FGM: type II/III vs. I 4.83 (1.34) .54 3.60***
 FGM: noFGM vs. type I 0.33 (2.15) .03 0.15
Step 2 (F(3,161) = 32.2, p < .001, adjusted R2 = .36, f2 = .60)
 (Intercept) −2.78 (0.96) −.32 −3.00**
 FGM: type II/III vs. I 3.58 (1.12) .40 3.19**
 FGM: noFGM vs. type I 1.81 (1.79) .20 1.01
 LTE 2.68 (0.31) .69 8.68***
Step 3 (F(5,159) = 26.5, p < .001, adjusted R2 = .44, f2 = .83)
 (Intercept) 0.18 (1.12) .02 0.16
 FGM: type II/III vs. I −1.21 (1.45) −.13 −0.83
 FGM: noFGM vs. type I −0.50 (2.12) −.05 −0.23
 LTE 0.47 (0.56) .12 0.85
 Interaction: FGM type II/III vs. I and LTE 3.15 (0.66) .81 4.76***
 Interaction: FGM: noFGM vs. type I and LTE 1.30 (1.38) .34 0.95
  1. Unstandardized beta coefficients (beta) with standard error (SE), uncorrected standardized regression coefficients (β), and t-values (t) with *p ≤ .05, **p ≤ .01 and ***p ≤ .001 are reported
  2. FGM female genital mutilation, LTE lifetime traumatic events